BullFrog AI and EastBanc Technologies Seek to Fast-Track Biopharma Clinical Development

Partnership Helps Tackle Pharmaceutical’s Real-World Challenges in Search for Vaccines and Medication

BullFrog AI, Inc., a precision pharmaceutical company built around a powerful artificial intelligence (AI) platform, proudly announces its technology partnership with EastBanc Technologies. EastBanc Technologies will serve as a technical partner providing a world class team of AI scientists, mathematicians and software developers to enable BullFrog AI to strengthen their efforts and bring value to late stage clinical development programs in the biopharma industry.

“We are very excited about partnering with EastBanc Technologies. They have exceptional leadership and a world class team of engineers and scientists that will play important strategic and operational roles for BullFrog AI. This relationship brings us much closer to fulfilling our mission of finding the link between patients and therapies to improve lives,” said BullFrog AI’s Founder and CEO, Vin Singh. “This partnership puts us in a great position going into the launch of our extended seed round in June.”

“In these uncertain times, partnering with a leading AI provider like BullFrog AI is more critical than ever. Take the industry’s top data scientists, provide them with scientific algorithms developed by John Hopkins and the right technology and you will potentially fast track the search for vaccines or medications — this could be a game changer in times like the current COVID 19 crisis,” explained EastBanc Technologies’ CEO Philippe Lanier. “Our teams specialize in assisting customers to adopt an emerging approach to AI through automated, process-oriented data analytics that reduce insight-delivery-time and improve insight quality. Our methodology streamlines messy data pipelines and affirms the unified transparent app development and delivery processes.”

For more information on BullFrog AI, visit http://www.bullfrogai.com.

About BullFrog AI 
BullFrog AI is an innovator in artificial intelligence. Its proprietary bfLEAPTM analytics engine is the only tool of its kind, designed to analyze massive, complex, multi-factorial clinical data sets. BullFrog AI’s technology is poised to revolutionize drug development, enabling researchers and clinicians to match therapies to patients, streamlining clinical trials, reducing development costs and accelerating R&D cycle time to drug approval and commercial launch. BullFrog AI has an exceptional team of life science industry leaders, AI technologists, scientists, physicians and advisors, all determined to make BullFrog AI become the undisputed leader in precision medicine.

About EastBanc Technologies 
EastBanc Technologies has been working at the frontier of technology since 1999. Today, the firm provides full-lifecycle software development delivering flexible technology solutions that seamlessly integrate with existing systems—whether on premise or cloud. EastBanc Technologies partners with public and private sector clients to solve their most difficult technology challenges. Headquartered in Washington DC, the firm employs 200 people. To learn more, visit eastbanctech.com.

For more information regarding BullFrog AI, contact: 
Vin Singh 
Founder and CEO 
[email protected] 
Baltimore, Maryland


For Media Inquiries, please contact: 
Liz Thibodeau 
Thibodeau Media Group 
[email protected]

News Image

“This relationship brings us much closer to fulfilling our mission of finding the link between patients and therapies to improve lives,” said BullFrog AI’s Founder and CEO, Vin Singh.